Fulcrum Equity Management Buys New Position in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)


Share on StockTwits

Fulcrum Equity Management bought a new stake in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 24,724 shares of the company’s stock, valued at approximately $1,243,000.

A number of other large investors have also made changes to their positions in SBIO. tru Independence LLC bought a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $36,000. Keystone Financial Group bought a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $210,000. Koshinski Asset Management Inc. bought a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $237,000. Crescent Capital Consulting LLC bought a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $307,000. Finally, Cetera Investment Advisers bought a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter valued at approximately $392,000.

Shares of SBIO stock traded up $0.05 during mid-day trading on Thursday, reaching $48.06. The stock had a trading volume of 274 shares, compared to its average volume of 38,230. The firm’s 50 day simple moving average is $53.31 and its 200 day simple moving average is $50.85. ALPS Medical Breakthroughs ETF has a one year low of $32.23 and a one year high of $64.04.

Featured Article: Understanding Compound Annual Growth Rate (CAGR)

Want to see what other hedge funds are holding SBIO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO).

Institutional Ownership by Quarter for ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.